BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16862861)

  • 1. [Criteria to hepatitis C treatment response].
    Levi D; Tanno H; Descalzi V
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S50-2; discussion S74-82. PubMed ID: 16862861
    [No Abstract]   [Full Text] [Related]  

  • 2. Infection fighters. Hepatitis C and HIV.
    TreatmentUpdate; 2005; 17(1):7. PubMed ID: 17225318
    [No Abstract]   [Full Text] [Related]  

  • 3. Advisory panel: expand hepatitis therapy to HIV/AIDS patients.
    AIDS Policy Law; 2002 Jul; 17(12):2. PubMed ID: 12134793
    [No Abstract]   [Full Text] [Related]  

  • 4. Managing hepatitis C infection in HIV-positive patients.
    Craven DE; Nunes DP
    AIDS Clin Care; 2000 Sep; 12(9):71-5, 78. PubMed ID: 12170952
    [No Abstract]   [Full Text] [Related]  

  • 5. [HIV and hepatitis coinfection].
    Ingiliz P; Rockstroh JK
    Dtsch Med Wochenschr; 2005 Dec; 130 Suppl 5():S216-8. PubMed ID: 16435714
    [No Abstract]   [Full Text] [Related]  

  • 6. Current issues in hepatitis C, HIV co-infection discussed at lunch and learn.
    Monarch A
    Surviv News (Atlanta Ga); 2002 Sep; ():14. PubMed ID: 12765135
    [No Abstract]   [Full Text] [Related]  

  • 7. Co-infections. Fighting fatigue and depression in HCV/HIV co-infection.
    TreatmentUpdate; 2006; 18(1):2-3. PubMed ID: 17228457
    [No Abstract]   [Full Text] [Related]  

  • 8. Tuberculosis complicating hepatitis C treatment in HIV-infected patients.
    Pérez-Elías MJ; García-San Miguel L; González García J; Montes Ramírez ML; Muriel A; Machín-Lázaro JM; Martínez-Baltanás A; Zamora F; Moreno A; Martín-Dávila P; Quereda C; Gómez-Mampaso E; Moreno S
    Clin Infect Dis; 2009 Apr; 48(8):e82-5. PubMed ID: 19275500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of hepatitis C in patients with response and recurrence and in co-infected patients who had no response].
    Schroder T; Bessone F; Cavallaro S
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S57-9; discussion S74-82. PubMed ID: 16862863
    [No Abstract]   [Full Text] [Related]  

  • 10. Defining the standard of care: randomized controlled trials for the treatment of hepatitis C in the HIV-infected person.
    Sulkowski MS
    Hepatology; 2004 Apr; 39(4):906-8. PubMed ID: 15057892
    [No Abstract]   [Full Text] [Related]  

  • 11. Renewed hope in the treatment of hepatitis C virus infection.
    Vaamonde C; Boyle BA
    AIDS Read; 1999 Aug; 9(5):311-4. PubMed ID: 12737120
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of human immunodeficiency virus infection in patients infected with the hepatitis C virus.
    Valle Tovo C; Alves de Mattos A; Ribeiro de Souza A; Ferrari de Oliveira Rigo J; Lerias de Almeida PR; Galperim B; Riegel Santos B
    Liver Int; 2007 Feb; 27(1):40-6. PubMed ID: 17241379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia.
    Shire NJ; Horn PS; Rouster SD; Stanford S; Eyster ME; Sherman KE;
    Hepatology; 2006 Nov; 44(5):1146-57. PubMed ID: 17058240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of adverse effects of hepatitis C treatment].
    González Ballerga E; Fernández N; Losso M
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S61-4; discussion S74-82. PubMed ID: 16862865
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation and treatment of hepatitis C in patients with coexisting HIV infection.
    Parker SD
    MedGenMed; 2006 Sep; 8(3):56. PubMed ID: 17406183
    [No Abstract]   [Full Text] [Related]  

  • 16. Does iron reduction improve sustained viral responses to interferon monotherapy in hepatitis C patients? Maybe, but is this the right question?
    Shedlofsky SI
    Am J Gastroenterol; 2002 May; 97(5):1093-6. PubMed ID: 12014712
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic factors predicting response to interferon treatment for viral hepatitis C.
    Stärkel P
    Gut; 2008 Apr; 57(4):440-2. PubMed ID: 18334658
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of sequence configurations of the PKR-interacting HCV proteins from plasma and PBMC as predictors of response to interferon-alpha and ribavirin therapy in HIV-coinfected patients.
    Bolcic F; Bull L; Martinez L; Reynoso R; Salomon H; Arduino R; Barnett B; Quarleri J
    Intervirology; 2008; 51(4):261-4. PubMed ID: 18824873
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatitis C virus-related cirrhosis: is antiviral treatment mandatory?].
    Castera L; Roulot D; Trinchet JC; Beaugrand M
    Gastroenterol Clin Biol; 2001 May; 25(5):509-13. PubMed ID: 11521104
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of viral hepatitis in HIV-HBV-HCV co-infected patients].
    Manero E; Frider B; Landeira G
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S59-60; discussion S74-82. PubMed ID: 16862864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.